Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder

Recruiting Phase 1 Interventional Study
Alcohol Use Disorder
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 60
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
50 (estimated)
Sponsor
Newleos Therapeutics, Inc. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The primary goal of this Phase 1b clinical trial is to evaluate the effects of a novel TAAR1 receptor partial agonist (NTX-2001) in adults with Alcohol Use Disorder (AUD). The main questions this trial aims to answer are: * Does NTX-2001 affect alcohol consumption in adults with AUD? * Is NTX-2001 safe and well tolerated in adults with AUD? Researchers will compare the effects of NTX-2001 with m…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Has provided written informed consent for the study and is willing to comply with all requirements of the protocol 2. English speaker 3. Male or female, ≥21 and ≤60 years of age. 4. Has a body mass index (BMI) 18 to 35 kg/m2 inclusive. 5. Meets DSM-5 criteria for Alcohol Use …
Contacts

Newleos Therapeutics Clinical Trial Team

978-780-5937

clinicaltrials@newleos.com

CONTACT